Search

Your search keyword '"Lainscak, Mitja"' showing total 247 results
Start Over Author "Lainscak, Mitja" Journal european journal of heart failure
247 results on '"Lainscak, Mitja"'

1. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials

Author

Anker, Stefan D., primary, Friede, Tim, additional, von Bardeleben, Ralph Stephan, additional, Butler, Javed, additional, Khan, Muhammad Shahzeb, additional, Diek, Monika, additional, Heinrich, Jutta, additional, Geyer, Martin, additional, Placzek, Marius, additional, Ferrari, Roberto, additional, Abraham, William T., additional, Alfieri, Ottavio, additional, Auricchio, Angelo, additional, Bayes‐Genis, Antoni, additional, Cleland, John G.F., additional, Filippatos, Gerasimos, additional, Gustafsson, Finn, additional, Haverkamp, Wilhelm, additional, Kelm, Malte, additional, Kuck, Karl‐Heinz, additional, Landmesser, Ulf, additional, Maggioni, Aldo P., additional, Metra, Marco, additional, Ninios, Vlasis, additional, Petrie, Mark C., additional, Rassaf, Tienush, additional, Ruschitzka, Frank, additional, Schäfer, Ulrich, additional, Schulze, P. Christian, additional, Spargias, Konstantinos, additional, Vahanian, Alec, additional, Zamorano, Jose Luis, additional, Zeiher, Andreas, additional, Karakas, Mahir, additional, Koehler, Friedrich, additional, Lainscak, Mitja, additional, Öner, Alper, additional, Mezilis, Nikolaos, additional, Theofilogiannakos, Efstratios K, additional, Ninios, Ilias, additional, Chrissoheris, Michael, additional, Kourkoveli, Panagiota, additional, Papadopoulos, Konstantinos, additional, Smolka, Grzegorz, additional, Wojakowski, Wojciech, additional, Reczuch, Krzysztof, additional, Pinto, Fausto J., additional, Zmudka, Krzysztof, additional, Kalarus, Zbigniew, additional, Adamo, Marianna, additional, Santiago‐Vacas, Evelyn, additional, Ruf, Tobias Friedrich, additional, Gross, Michael, additional, Tongers, Joern, additional, Hasenfuß, Gerd, additional, Schillinger, Wolfgang, additional, and Ponikowski, Piotr, additional

Published
2024
Full Text
View/download PDF

2. Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC

Author

Rosano, Giuseppe M.C., primary, Stolfo, Davide, additional, Anderson, Lisa, additional, Abdelhamid, Magdy, additional, Adamo, Marianna, additional, Bauersachs, Johann, additional, Bayes‐Genis, Antoni, additional, Böhm, Michael, additional, Chioncel, Ovidiu, additional, Filippatos, Gerasimos, additional, Hill, Loreena, additional, Lainscak, Mitja, additional, Lambrinou, Ekaterini, additional, Maas, Angela H.E.M., additional, Massouh, Angela R., additional, Moura, Brenda, additional, Petrie, Mark C., additional, Rakisheva, Amina, additional, Ray, Robin, additional, Savarese, Gianluigi, additional, Skouri, Hadi, additional, Van Linthout, Sophie, additional, Vitale, Cristiana, additional, Volterrani, Maurizio, additional, Metra, Marco, additional, and Coats, Andrew J.S., additional

Published
2024
Full Text
View/download PDF

3. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC

Author

Savarese, Gianluigi, primary, Lindberg, Felix, additional, Cannata, Antonio, additional, Chioncel, Ovidiu, additional, Stolfo, Davide, additional, Musella, Francesca, additional, Tomasoni, Daniela, additional, Abdelhamid, Magdy, additional, Banerjee, Debasish, additional, Bayes‐Genis, Antoni, additional, Berthelot, Emmanuelle, additional, Braunschweig, Frieder, additional, Coats, Andrew J.S., additional, Girerd, Nicolas, additional, Jankowska, Ewa A., additional, Hill, Loreena, additional, Lainscak, Mitja, additional, Lopatin, Yury, additional, Lund, Lars H., additional, Maggioni, Aldo P., additional, Moura, Brenda, additional, Rakisheva, Amina, additional, Ray, Robin, additional, Seferovic, Petar M., additional, Skouri, Hadi, additional, Vitale, Cristiana, additional, Volterrani, Maurizio, additional, Metra, Marco, additional, and Rosano, Giuseppe M.C., additional

Published
2024
Full Text
View/download PDF

4. Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Author

Harjola, Veli-Pekka, Mullens, Wilfried, Banaszewski, Marek, Bauersachs, Johann, Brunner-La Rocca, Hans-Peter, Chioncel, Ovidiu, Collins, Sean, Doehner, Wolfram, Filippatos, Gerasimos, Flammer, Andreas, Fuhrmann, Valentin, Lainscak, Mitja, Lassus, Johan, Legrand, Matthieu, Masip, Josep, Mueller, Christian, Papp, Zoltán, Parissis, John, Platz, Elke, Rudiger, Alain, Ruschitzka, Frank, Schäfer, Andreas, Seferovic, Petar, Skouri, Hadi, Yilmaz, Mehmet, and Mebazaa, Alexandre

Subjects
Heart failure, Multiple organ failure, Venous congestion, Acute Disease, Cardiology, Diagnostic Imaging, Disease Management, Europe, Heart Failure, Humans, Multiple Organ Failure, Societies, Medical
Abstract

Organ injury and impairment are commonly observed in patients with acute heart failure (AHF), and congestion is an essential pathophysiological mechanism of impaired organ function. Congestion is the predominant clinical profile in most patients with AHF; a smaller proportion presents with peripheral hypoperfusion or cardiogenic shock. Hypoperfusion further deteriorates organ function. The injury and dysfunction of target organs (i.e. heart, lungs, kidneys, liver, intestine, brain) in the setting of AHF are associated with increased risk for mortality. Improvement in organ function after decongestive therapies has been associated with a lower risk for post-discharge mortality. Thus, the prevention and correction of organ dysfunction represent a therapeutic target of interest in AHF and should be evaluated in clinical trials. Treatment strategies that specifically prevent, reduce or reverse organ dysfunction remain to be identified and evaluated to determine if such interventions impact mortality, morbidity and patient-centred outcomes. This paper reflects current understanding among experts of the presentation and management of organ impairment in AHF and suggests priorities for future research to advance the field.

Published
2017

5. Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC‐HFA Heart Failure Long‐Term Registry

Author

Adamo, Marianna, primary, Chioncel, Ovidiu, additional, Benson, Lina, additional, Shahim, Bahira, additional, Crespo‐Leiro, Maria G., additional, Anker, Stefan D., additional, Coats, Andrew J.S., additional, Filippatos, Gerasimos, additional, Lainscak, Mitja, additional, McDonagh, Theresa, additional, Mebazaa, Alexander, additional, Piepoli, Massimo F., additional, Rosano, Giuseppe M.C., additional, Ruschitzka, Frank, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Shahim, Angiza, additional, Popescu, Bogdan A., additional, Iung, Bernard, additional, Volterrani, Maurizio, additional, Maggioni, Aldo P., additional, Metra, Marco, additional, and Lund, Lars H., additional

Published
2023
Full Text
View/download PDF

6. Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long‐Term Registry

Author

Shahim, Bahira, primary, Shahim, Angiza, additional, Adamo, Marianna, additional, Chioncel, Ovidiu, additional, Benson, Lina, additional, Shahim, Bahira, additional, Crespo‐Leiro, Maria G., additional, Anker, Stefan D., additional, Coats, Andrew J.S., additional, Filippatos, Gerasimos, additional, Lainscak, Mitja, additional, McDonagh, Theresa, additional, Mebazaa, Alexandre, additional, Piepoli, Massimo F., additional, Rosano, Giuseppe M.C., additional, Ruschitzka, Frank, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Volterrani, Maurizio, additional, Leiro, Marisa Crespo, additional, Cubero, Javier Segovia, additional, Amir, Offer, additional, Palic, Benjamin, additional, Maggioni, Aldo P., additional, Metra, Marco, additional, and Lund, Lars H., additional

Published
2023
Full Text
View/download PDF

7. Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: a scientific statement by the Heart Failure Association ( HFA ) of the ESC

Author

Metra, Marco, primary, Adamo, Marianna, additional, Tomasoni, Daniela, additional, Mebazaa, Alexandre, additional, Bayes‐Genis, Antoni, additional, Abdelhamid, Magdy, additional, Adamopoulos, Stamatis, additional, Anker, Stefan D., additional, Bauersachs, Johann, additional, Belenkov, Yuri, additional, Böhm, Michael, additional, Gal, Tuvia Ben, additional, Butler, Javed, additional, Cohen‐Solal, Alain, additional, Filippatos, Gerasimos, additional, Gustafsson, Finn, additional, Hill, Loreena, additional, Jaarsma, Tiny, additional, Jankowska, Ewa A., additional, Lainscak, Mitja, additional, Lopatin, Yuri, additional, Lund, Lars, additional, McDonagh, Theresa, additional, Milicic, Davor, additional, Moura, Brenda, additional, Mullens, Wilfried, additional, Piepoli, Massimo, additional, Polovina, Marija, additional, Ponikowski, Piotr, additional, Rakisheva, Amina, additional, Ristic, Arsen, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Sharma, Rajan, additional, Thum, Thomas, additional, Tocchetti, Carlo G., additional, Van Linthout, Sophie, additional, Vitale, Cristiana, additional, Von Haehling, Stephan, additional, Volterrani, Maurizio, additional, Coats, Andrew JS, additional, Chioncel, Ovidiu, additional, and Rosano, Giuseppe, additional

Published
2023
Full Text
View/download PDF

8. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

Author

McDonagh, Theresa A., Metra, Marco, Adamo, Marianna, Gardner, Roy S., Baumbach, Andreas, Böhm, Michael, Burri, Haran, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G.F., Crespo‐Leiro, Maria Generosa, Farmakis, Dimitrios, Gilard, Martine, Heymans, Stephane, Hoes, Arno W., Jaarsma, Tiny, Jankowska, Ewa A., Lainscak, Mitja, and Lam, Carolyn S.P.

Subjects
HEART failure, TASK forces, CARDIOLOGY, DIAGNOSIS, ELECTRONIC journals, AFRIKANERS
Abstract

Document Reviewers: Rudolf A. de Boer (CPG Review Co‐ordinator) (Netherlands), P. Christian Schulze (CPG Review Co‐ordinator) (Germany), Elena Arbelo (Spain), Jozef Bartunek (Belgium), Johann Bauersachs (Germany), Michael A. Borger (Germany), Sergio Buccheri (Sweden), Elisabetta Cerbai (Italy), Erwan Donal (France), Frank Edelmann (Germany), Gloria Färber (Germany), Bettina Heidecker (Germany), Borja Ibanez (Spain), Stefan James (Sweden), Lars Køber (Denmark), Konstantinos C. Koskinas (Switzerland), Josep Masip (Spain), John William McEvoy (Ireland), Robert Mentz (United States of America), Borislava Mihaylova (United Kingdom), Jacob Eifer Møller (Denmark), Wilfried Mullens (Belgium), Lis Neubeck (United Kingdom), Jens Cosedis Nielsen (Denmark), Agnes A. Pasquet (Belgium), Piotr Ponikowski (Poland), Eva Prescott (Denmark), Amina Rakisheva (Kazakhstan), Bianca Rocca (Italy), Xavier Rossello (Spain), Leyla Elif Sade (United States of America/Türkiye), Hannah Schaubroeck (Belgium), Elena Tessitore (Switzerland), Mariya Tokmakova (Bulgaria), Peter van der Meer (Netherlands), Isabelle C. Van Gelder (Netherlands), Mattias Van Heetvelde (Belgium), Christiaan Vrints (Belgium), Matthias Wilhelm (Switzerland), Adam Witkowski (Poland), and Katja Zeppenfeld (Netherlands) All experts involved in the development of this Focused Update have submitted declarations of interest. These have been compiled in a report and simultaneously published in a supplementary document to the Focused Update. The report is also available on the ESC website www.escardio.org/guidelines See the European Heart Journal online for supplementary documents that include evidence tables. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery.

Author

Lund, Lars H., Crespo‐Leiro, Maria Generosa, Laroche, Cecile, Garcia‐Pinilla, Jose M., Bennis, Ahmed, Vataman, Eleonora B., Polovina, Marija, Radovanovic, Slavica, Apostolovic, Svetlana R., Ašanin, Milika, Gackowski, Andrzej, Kaplon‐Cieslicka, Agnieszka, Cabac‐Pogorevici, Irina, Anker, Stefan D., Chioncel, Ovidiu, Coats, Andrew J.S., Filippatos, Gerasimos, Lainscak, Mitja, Mcdonagh, Theresa, and Mebazaa, Alexandre

Subjects
HEART failure, VENTRICULAR ejection fraction, GOVERNMENT policy
Abstract

Aims: Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline‐recommended therapy in Europe and other ESC affiliated countries. Methods: Between 1 November 2018 and 31 December 2020, 10 162 patients with chronic or acute/worsening HF with reduced, mildly reduced, or preserved ejection fraction were enrolled from 220 centres in 41 European or ESC affiliated countries. The ESC HF III Registry collected data on baseline characteristics (hospital or clinic presentation), hospital course, diagnostic and therapeutic decisions in hospital and at the clinic visit; and on outcomes at 12‐month follow‐up. These data include demographics, medical history, physical examination, biomarkers and imaging, quality of life, treatments, and interventions – including drug doses and reasons for non‐use, and cause‐specific outcomes. Conclusion: The ESC HF III Registry will provide comprehensive and unique insight into contemporary HF characteristics, treatment implementation, and outcomes, and may impact implementation strategies, clinical discovery, trial design, and public policy. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association ( HFA ) of the ESC

Author

Metra, Marco, primary, Tomasoni, Daniela, additional, Adamo, Marianna, additional, Bayes‐Genis, Antoni, additional, Filippatos, Gerasimos, additional, Abdelhamid, Magdy, additional, Adamopoulos, Stamatis, additional, Anker, Stefan D., additional, Antohi, Laura, additional, Böhm, Michael, additional, Braunschweig, Frieder, additional, Gal, Tuvia Ben, additional, Butler, Javed, additional, Cleland, John G.F., additional, Cohen‐Solal, Alain, additional, Damman, Kevin, additional, Gustafsson, Finn, additional, Hill, Loreena, additional, Jankowska, Ewa, additional, Lainscak, Mitja, additional, Lund, Lars H., additional, McDonagh, Theresa, additional, Mebazaa, Alexandre, additional, Moura, Brenda, additional, Mullens, Wilfried, additional, Piepoli, Massimo, additional, Ponikowski, Piotr, additional, Rakisheva, Amina, additional, Ristic, Arsen, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Sharma, Rajan, additional, Tocchetti, Carlo Gabriele, additional, Yılmaz, Mehmet Birhan, additional, Vitale, Cristiana, additional, Volterrani, Maurizio, additional, Von Haehling, Stephan, additional, Chioncel, Ovidiu, additional, Coats, Andrew JS, additional, and Rosano, Giuseppe, additional

Published
2023
Full Text
View/download PDF

11. Bone status in men with heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure

Author

Loncar, Goran, primary, Garfias‐Veitl, Tania, additional, Valentova, Miroslava, additional, Vatic, Mirela, additional, Lainscak, Mitja, additional, Obradović, Danilo, additional, Dschietzig, Thomas Bernd, additional, Doehner, Wolfram, additional, Jankowska, Ewa A., additional, Anker, Stefan D., additional, and von Haehling, Stephan, additional

Published
2023
Full Text
View/download PDF

12. Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes – from the ESC‐HFA EORP Heart Failure Long‐Term Registry.

Author

Kapłon‐Cieślicka, Agnieszka, Benson, Lina, Chioncel, Ovidiu, Crespo‐Leiro, Maria G., Coats, Andrew J.S., Anker, Stefan D., Ruschitzka, Frank, Hage, Camilla, Drożdż, Jarosław, Seferovic, Petar, Rosano, Giuseppe M.C., Piepoli, Massimo, Mebazaa, Alexandre, McDonagh, Theresa, Lainscak, Mitja, Savarese, Gianluigi, Ferrari, Roberto, Mullens, Wilfried, Bayes‐Genis, Antoni, and Maggioni, Aldo P.

Subjects
HEART failure, SYSTOLIC blood pressure, ACE inhibitors, ANGIOTENSIN-receptor blockers, HOSPITAL mortality
Abstract

Aims: To comprehensively assess hyponatraemia in acute heart failure (AHF) regarding prevalence, associations, hospital course, and post‐discharge outcomes. Methods and results: Of 8298 patients in the European Society of Cardiology Heart Failure Long‐Term Registry hospitalized for AHF with any ejection fraction, 20% presented with hyponatraemia (serum sodium <135 mmol/L). Independent predictors included lower systolic blood pressure, estimated glomerular filtration rate (eGFR) and haemoglobin, along with diabetes, hepatic disease, use of thiazide diuretics, mineralocorticoid receptor antagonists, digoxin, higher doses of loop diuretics, and non‐use of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers and beta‐blockers. In‐hospital death occurred in 3.3%. The prevalence of hyponatraemia and in‐hospital mortality with different combinations were: 9% hyponatraemia both at admission and discharge (hyponatraemia Yes/Yes, in‐hospital mortality 6.9%), 11% Yes/No (in‐hospital mortality 4.9%), 8% No/Yes (in‐hospital mortality 4.7%), and 72% No/No (in‐hospital mortality 2.4%). Correction of hyponatraemia was associated with improvement in eGFR. In‐hospital development of hyponatraemia was associated with greater diuretic use and worsening eGFR but also more effective decongestion. Among hospital survivors, 12‐month mortality was 19% and adjusted hazard ratios (95% confidence intervals) were for hyponatraemia Yes/Yes 1.60 (1.35–1.89), Yes/No 1.35 (1.14–1.59), and No/Yes 1.18 (0.96–1.45). For death or heart failure hospitalization they were 1.38 (1.21–1.58), 1.17 (1.02–1.33), and 1.09 (0.93–1.27), respectively. Conclusion: Among patients with AHF, 20% had hyponatraemia at admission, which was associated with more advanced heart failure and normalized in half of patients during hospitalization. Admission hyponatraemia (possibly dilutional), especially if it did not resolve, was associated with worse in‐hospital and post‐discharge outcomes. Hyponatraemia developing during hospitalization (possibly depletional) was associated with lower risk. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

13. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the <scp>ESC‐HFA EORP</scp> Heart Failure Long‐Term Registry

Author

Kapłon-Cieślicka, Agnieszka, Benson, Lina, Chioncel, Ovidiu, Crespo-Leiro, Maria G, Coats, Andrew J S, Anker, Stefan D, Filippatos, Gerasimos, Ruschitzka, Frank, Hage, Camilla, Drożdż, Jarosław, Seferovic, Petar, Rosano, Giuseppe M C, Piepoli, Massimo, Mebazaa, Alexandre, McDonagh, Theresa, Lainscak, Mitja, Savarese, Gianluigi, Ferrari, Roberto, Maggioni, Aldo P, Lund, Lars H, University of Zurich, and Lund, Lars H

Subjects
Heart failure with mildly reduced ejection fraction, Heart Failure, Heart failure with mid-range ejection fraction, Aftercare, 610 Medicine & health, Stroke Volume, Prognosis, 2705 Cardiology and Cardiovascular Medicine, Patient Discharge, Hospitalization, Treatment, Heart failure with preserved ejection fraction, 10209 Clinic for Cardiology, Humans, Registries, Cardiology and Cardiovascular Medicine
Abstract

[Abstract] Aims: To perform a comprehensive characterization of acute heart failure (AHF) with preserved (HFpEF), versus mildly reduced (HFmrEF) versus reduced ejection fraction (HFrEF). Methods and results: Of 5951 participants in the ESC HF Long-Term Registry hospitalized for AHF (acute coronary syndromes excluded), 29% had HFpEF, 18% HFmrEF, and 53% HFrEF. Hospitalization reasons were most commonly atrial fibrillation (more in HFmrEF and HFpEF), followed by ischaemia (HFmrEF), infection (HFmrEF and HFpEF), worsening renal function (HFrEF), and uncontrolled hypertension (HFmrEF and HFpEF). Hospitalization characteristics included lower blood pressure, more oedema and higher natriuretic peptides with lower ejection fraction, similar pulmonary congestion, more mitral regurgitation in HFrEF and HFmrEF and more tricuspid regurgitation in HFrEF. In-hospital mortality was 3.4% in HFrEF, 2.1% in HFmrEF and 2.2% in HFpEF. Intravenous diuretic (∼80%) and nitrate (∼15%) use was similar but inotrope use greater in HFrEF (16%, vs. HFmrEF 7.4% vs. HFpEF 5.3%). Weight loss and estimated glomerular filtration rate improvement were greater in HFrEF, whereas reduction in natriuretic peptides was similar. Over 1 year post-discharge, events per 100 patient-years (95% confidence interval) in HFrEF versus HFmrEF versus HFpEF were: all-cause death 22 (20-24) versus 17 (14-20) versus 17 (15-20); cardiovascular (CV) death 12 (10-13) versus 8.6 (6.6-11) versus 8.4 (6.9-10); non-CV death 2.4 (1.8-3.1) versus 3.3 (2.1-4.8) versus 4.5 (3.5-5.9); all-cause hospitalization 48 (45-51) versus 35 (31-40) versus 42 (39-46); HF hospitalization 29 (27-32) versus 19 (16-22) versus 17 (15-20); and non-CV hospitalization 7.7 (6.6-8.9) versus 9.6 (7.5-12) versus 15 (13-17). Conclusion: In AHF, HFrEF is more severe and has greater in-hospital mortality. Post-discharge, HFrEF has greater CV risk, HFpEF greater non-CV risk, and HFmrEF lower overall risk.

Published
2022

14. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology

Author

Gorter, Thomas M., van Veldhuisen, Dirk J., Bauersachs, Johann, Borlaug, Barry A., Celutkiene, Jelena, Coats, Andrew J.S., Crespo‐Leiro, Marisa G., Guazzi, Marco, Harjola, Veli‐Pekka, Heymans, Stephane, Hill, Loreena, Lainscak, Mitja, Lam, Carolyn S.P., Lund, Lars H., Lyon, Alexander R., Mebazaa, Alexandre, Mueller, Christian, Paulus, Walter J., Pieske, Burkert, Piepoli, Massimo F., Ruschitzka, Frank, Rutten, Frans H., Seferovic, Petar M., Solomon, Scott D., Shah, Sanjiv J., Triposkiadis, Filippos, Wachter, Rolf, Tschöpe, Carsten, and de Boer, Rudolf A.

Published
2018
Full Text
View/download PDF

15. Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long‐Term Registry

Author

Canepa, Marco, Straburzynska‐Migaj, Ewa, Drozdz, Jaroslaw, Fernandez‐Vivancos, Carla, Pinilla, Jose Manuel Garcia, Nyolczas, Noemi, Temporelli, Pier Luigi, Mebazaa, Alexandre, Lainscak, Mitja, Laroche, Cécile, Maggioni, Aldo Pietro, Piepoli, Massimo F., Coats, Andrew J.S., Ferrari, Roberto, and Tavazzi, Luigi

Published
2018
Full Text
View/download PDF

16. Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology

Author

Corrà, Ugo, Agostoni, Pier Giuseppe, Anker, Stefan D., Coats, Andrew J.S., Crespo Leiro, Maria G., de Boer, Rudolph A., Hairola, Veli‐Pekka, Hill, Loreena, Lainscak, Mitja, Lund, Lars H., Metra, Marco, Ponikowski, Piotr, Riley, Jillian, Seferović, Petar M., and Piepoli, Massimo F.

Published
2018
Full Text
View/download PDF

17. Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry

Author

Chioncel, Ovidiu, Lainscak, Mitja, Seferovic, Petar M., Anker, Stefan D., Crespo‐Leiro, Maria G., Harjola, Veli‐Pekka, Parissis, John, Laroche, Cecile, Piepoli, Massimo Francesco, Fonseca, Candida, Mebazaa, Alexandre, Lund, Lars, Ambrosio, Giuseppe A., Coats, Andrew J., Ferrari, Roberto, Ruschitzka, Frank, Maggioni, Aldo P., and Filippatos, Gerasimos

Published
2017
Full Text
View/download PDF

18. ‘heartfailurematters.org’, an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions

Author

Wagenaar, Kim P., Rutten, Frans H., Klompstra, Leonie, Bhana, Yusuf, Sieverink, Floor, Ruschitzka, Frank, Seferovic, Petar M., Lainscak, Mitja, Piepoli, Massimo F., Broekhuizen, Berna D.L., Strömberg, Anna, Jaarsma, Tiny, Hoes, Arno W., and Dickstein, Kenneth

Published
2017
Full Text
View/download PDF

19. Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC.

Author

Metra, Marco, Adamo, Marianna, Tomasoni, Daniela, Mebazaa, Alexandre, Bayes‐Genis, Antoni, Abdelhamid, Magdy, Adamopoulos, Stamatis, Anker, Stefan D., Bauersachs, Johann, Belenkov, Yuri, Böhm, Michael, Gal, Tuvia Ben, Butler, Javed, Cohen‐Solal, Alain, Filippatos, Gerasimos, Gustafsson, Finn, Hill, Loreena, Jaarsma, Tiny, Jankowska, Ewa A., and Lainscak, Mitja

Subjects
HEART failure, HEART failure patients, THERAPEUTICS
Abstract

Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked increases in death and rehospitalization rates, which then decline exponentially though they remain higher than in patients without a recent hospitalization. Therefore, optimal management of patients with acute heart failure before discharge and in the early post‐discharge phase is critical. First, it may prevent rehospitalizations through the early detection and effective treatment of residual or recurrent congestion, the main manifestation of decompensation. Second, initiation at pre‐discharge and titration to target doses in the early post‐discharge period, of guideline‐directed medical therapy may improve both short‐ and long‐term outcomes. Third, in chronic heart failure, medical treatment is often left unchanged, so the acute heart failure hospitalization presents an opportunity for implementation of therapy. The aim of this scientific statement by the Heart Failure Association of the European Society of Cardiology is to summarize recent findings that have implications for clinical management both in the pre‐discharge and the early post‐discharge phase after a hospitalization for acute heart failure. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

20. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology.

Author

Metra, Marco, Tomasoni, Daniela, Adamo, Marianna, Bayes‐Genis, Antoni, Filippatos, Gerasimos, Abdelhamid, Magdy, Adamopoulos, Stamatis, Anker, Stefan D., Antohi, Laura, Böhm, Michael, Braunschweig, Frieder, Gal, Tuvia Ben, Butler, Javed, Cleland, John G.F., Cohen‐Solal, Alain, Damman, Kevin, Gustafsson, Finn, Hill, Loreena, Jankowska, Ewa A., and Lainscak, Mitja

Subjects
HEART failure, PHYSICIANS, HEART failure patients, SYMPTOMS, EPIDEMIOLOGY, PERIPARTUM cardiomyopathy
Abstract

Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline‐recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes of worsening HF is an essential component of HF treatment and this may be achieved through early and rapid administration of GRMT. The aim of the present clinical consensus statement by the Heart Failure Association of the European Society of Cardiology is to provide an update on the definition, clinical characteristics, management and prevention of worsening HF in clinical practice. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology

Author

Seferović, Peter, primary, Farmakis, Dimitrios, additional, Bayes‐Genis, Antoni, additional, Ben Gal, Tuvia, additional, Böhm, Michael, additional, Chioncel, Ovidiu, additional, Ferrari, Roberto, additional, Filippatos, Gerasimos, additional, Hill, Loreena, additional, Jankowska, Ewa, additional, Lainscak, Mitja, additional, Lopatin, Yuri, additional, Lund, Lars H., additional, Mebazaa, Alexandre, additional, Metra, Marco, additional, Moura, Brenda, additional, Rosano, Giuseppe, additional, Thum, Thomas, additional, Voors, Adriaan, additional, and Coats, Andrew J.S., additional

Published
2022
Full Text
View/download PDF

24. Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme

Author

Seferovic, Petar M., Piepoli, Massimo F., Lopatin, Yuri, Jankowska, Ewa, Polovina, Marija, Anguita-Sanchez, Manuel, Stoerk, Stefan, Lainscak, Mitja, Milicic, Davor, Milinkovic, Ivan, Filippatos, Gerasimos, Coats, Andrew J. S., Anker, Stefan, Backs, Johannes, Bauersachs, Johann, Ben Gal, Tuvia, de Boer, Rudolf A., Doehner, Wolfram, Celutkiene, Jelena, Chioncel, Ovidiu, Heymans, Stephane, Hill, Loreena, Jaarsma, Tiny, Lund, Lars H., Lyon, Alexander R., Metra, Marco, Moura, Brenda, Mueller, Cristian, Mullens, Wilfried, Ponikowski, Piotr, Rosano, Giuseppe, Ruschitzka, Frank, Thum, Thomas, Volterrani, Maurizio, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, and Cardiovascular Centre (CVC)

Subjects
medicine.medical_specialty, Cardiology, Heart failure, Audit, ORGANIZATION, 030204 cardiovascular system & hematology, Accreditation, DISEASE MANAGEMENT PROGRAMS, 03 medical and health sciences, 0302 clinical medicine, Multidisciplinary approach, Internal medicine, Intensive care, Health care, Disease management, Medicine, Humans, Disease management (health), Human resources, Quality of Health Care, Heart Failure, Patient, business.industry, Research, Multidisciplinary care, Quality of care, ADMISSION, 3. Good health, CLINICS, Europe, SURVIVAL, Cardiology and Cardiovascular Medicine, business, Hospital accreditation, Editorial Comment, INTERVENTION, MULTIDISCIPLINARY
Abstract

Heart failure (HF) is the major contributor to cardiovascular morbidity and mortality. Given its rising prevalence, the costs of HF care can be expected to increase. Multidisciplinary management of HF can improve quality of care and survival. However, specialized HF programmes are not widely available in most European countries. These circumstances underlie the suggestion of the Heart Failure Association (HFA)of the European Society of Cardiology (ESC) for the development of quality of care centres (QCCs). These are defined as health care institutions that provide multidisciplinary HF management at all levels of care (primary, secondary and tertiary), are accredited by the HFA/ESC and are implemented into existing health care systems. Their major goals are to unify and improve the quality of HF care, and to promote collaboration in education and research activities. Three types of QCC are suggested: community QCCs (primary care facilities able to provide non-invasive assessment and optimal therapy); specialized QCCs (district hospitals with intensive care units, able to provide cardiac catheterization and device implantation services), and advanced QCCs (national reference centres able to deliver advanced and innovative HF care and research). QCC accreditation will require compliance with general and specific HFA/ESC accreditation standards. General requirements include confirmation of the centre's existence, commitment to QCC implementation, and collaboration with other QCCs. Specific requirements include validation of the centre's level of care, service portfolio, facilities and equipment, management, human resources, process measures, quality indicators and outcome measures. Audit and recertification at 4-6-year intervals are also required. The implementation of QCCs will evolve gradually, following a pilot phase in selected countries. The present document summarizes the definition, major goals, development, classification and crucial aspects of the accreditation process of the HFA/ESC QCC Programme.

Published
2020

25. Education and certification on heart failure of the H eart F ailure A ssociation of the E uropean S ociety of C ardiology

Author

Mullens, Wilfried, primary, Coats, Andrew, additional, Seferovic, Petar, additional, Metra, Marco, additional, Mebazaa, Alexandre, additional, Ruschitzka, Frank, additional, Filippatos, Gerasimos, additional, Volterrani, Maurizio, additional, Ponikowski, Piotr, additional, Jankowska, Ewa A., additional, Chioncel, Ovidiu, additional, McDonagh, Theresa A., additional, Piepoli, Massimo F., additional, Milicic, Davor, additional, Thum, Thomas, additional, Hill, Loreena, additional, Abdelhamid, Magdy, additional, Adamopoulos, Stamatis, additional, Belenkov, Yuri, additional, Ben Gal, Tuvia, additional, Böhm, Michael, additional, Cohen‐Solal, Alain, additional, Gustafsson, Finn, additional, Jaarsma, Tiny, additional, Moura, Brenda, additional, Rakisheva, Amina, additional, Ristic, Arsen, additional, Bayes‐Genis, Antonio, additional, Van Linthout, Sophie, additional, Anker, Stefan D., additional, Tocchetti, Carlo Gabriele, additional, Lopatin, Yury, additional, Lund, Lars, additional, Savarese, Gianluigi, additional, Čelutkienė, Jelena, additional, Cowie, Martin, additional, Lambrinou, Ekaterini, additional, Ray, Robin, additional, Lainscak, Mitja, additional, Skouri, Hadi, additional, Wallner, Markus, additional, and Rosano, Giuseppe M.C., additional

Published
2022
Full Text
View/download PDF

26. European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology

Author

Aktaa, Suleman, primary, Polovina, Marija, additional, Rosano, Giuseppe, additional, Abdin, Amr, additional, Anguita, Manuel, additional, Lainscak, Mitja, additional, Lund, Lars H., additional, McDonagh, Theresa, additional, Metra, Marco, additional, Mindham, Richard, additional, Piepoli, Massimo, additional, Störk, Stefan, additional, Tokmakova, Mariya P., additional, Seferović, Petar, additional, Gale, Chris P., additional, and Coats, Andrew J.S., additional

Published
2022
Full Text
View/download PDF

27. Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

Author

Piepoli, Massimo F., primary, Adamo, Marianna, additional, Barison, Andrea, additional, Bestetti, Reinaldo B., additional, Biegus, Jan, additional, Böhm, Michael, additional, Butler, Javed, additional, Carapetis, Jonathan, additional, Ceconi, Claudio, additional, Chioncel, Ovidiu, additional, Coats, Andrew, additional, Crespo‐Leiro, Maria G., additional, de Simone, Giovanni, additional, Drexel, Heinz, additional, Emdin, Michele, additional, Farmakis, Dimitros, additional, Halle, Martin, additional, Heymans, Stephane, additional, Jaarsma, Tiny, additional, Jankowska, Ewa, additional, Lainscak, Mitja, additional, Lam, Carolyn S.P., additional, Løchen, Maja‐Lisa, additional, Lopatin, Yuri, additional, Maggioni, Aldo, additional, Matrone, Benedetta, additional, Metra, Marco, additional, Noonan, Katharine, additional, Pina, Ileana, additional, Prescott, Eva, additional, Rosano, Giuseppe, additional, Seferovic, Petar M., additional, Sliwa, Karen, additional, Stewart, Simon, additional, Uijl, Alicia, additional, Vaartjes, Ilonca, additional, Vermeulen, Roel, additional, Monique Verschuren, W. M., additional, Volterrani, Maurizio, additional, von Haehling, Stephan, additional, and Hoes, Arno, additional

Published
2022
Full Text
View/download PDF

28. COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

Author

Rosano, Giuseppe, primary, Jankowska, Ewa A., additional, Ray, Robin, additional, Metra, Marco, additional, Abdelhamid, Magdy, additional, Adamopoulos, Stamatis, additional, Anker, Stefan D., additional, Bayes‐Genis, Antoni, additional, Belenkov, Yury, additional, Ben Gal, Tuvia, additional, Böhm, Michael, additional, Chioncel, Ovidiu, additional, Cohen‐Solal, Alain, additional, Farmakis, Dimitrios, additional, Filippatos, Gerasimos, additional, González, Arantxa, additional, Gustafsson, Finn, additional, Hill, Loreena, additional, Jaarsma, Tiny, additional, Jouhra, Fadi, additional, Lainscak, Mitja, additional, Lambrinou, Ekaterini, additional, Lopatin, Yury, additional, Lund, Lars H., additional, Milicic, Davor, additional, Moura, Brenda, additional, Mullens, Wilfried, additional, Piepoli, Massimo F., additional, Ponikowski, Piotr, additional, Rakisheva, Amina, additional, Ristic, Arsen, additional, Savarese, Gianluigi, additional, Seferovic, Petar, additional, Senni, Michele, additional, Thum, Thomas, additional, Tocchetti, Carlo G., additional, Van Linthout, Sophie, additional, Volterrani, Maurizio, additional, and Coats, Andrew J.S., additional

Published
2021
Full Text
View/download PDF

32. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology

Author

Rosano, Giuseppe M.C., primary, Moura, Brenda, additional, Metra, Marco, additional, Böhm, Michael, additional, Bauersachs, Johann, additional, Ben Gal, Tuvia, additional, Adamopoulos, Stamatis, additional, Abdelhamid, Magdy, additional, Bistola, Vasiliki, additional, Čelutkienė, Jelena, additional, Chioncel, Ovidiu, additional, Farmakis, Dimitrios, additional, Ferrari, Roberto, additional, Filippatos, Gerasimos, additional, Hill, Loreena, additional, Jankowska, Ewa A., additional, Jaarsma, Tiny, additional, Jhund, Pardeep, additional, Lainscak, Mitja, additional, Lopatin, Yuri, additional, Lund, Lars H., additional, Milicic, Davor, additional, Mullens, Wilfried, additional, Pinto, Fausto, additional, Ponikowski, Piotr, additional, Savarese, Gianluigi, additional, Thum, Thomas, additional, Volterrani, Maurizio, additional, Anker, Stefan D., additional, Seferovic, Petar M., additional, and Coats, Andrew J.S., additional

Published
2021
Full Text
View/download PDF

36. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

Author

Maggioni, Aldo P., Anker, Stefan D., Dahlström, Ulf, Filippatos, Gerasimos, Ponikowski, Piotr, Zannad, Faiez, Amir, Offer, Chioncel, Ovidiu, Leiro, Marisa Crespo, Drozdz, Jaroslaw, Erglis, Andrejs, Fazlibegovic, Emir, Fonseca, Candida, Fruhwald, Friedrich, Gatzov, Plamen, Goncalvesova, Eva, Hassanein, Mahmoud, Hradec, Jaromir, Kavoliuniene, Ausra, Lainscak, Mitja, Logeart, Damien, Merkely, Bela, Metra, Marco, Persson, Hans, Seferovic, Petar, Temizhan, Ahmet, Tousoulis, Dimitris, and Tavazzi, Luigi

Published
2013
Full Text
View/download PDF

37. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups

Author

Seferović, Petar M., Stoerk, Stefan, Filippatos, Gerasimos, Mareev, Viacheslav, Kavoliuniene, Ausra, Ristić, Arsen D., Ponikowski, Piotr, McMurray, John, Maggioni, Aldo, Ruschitzka, Frank, van Veldhuisen, Dirk J., Coats, Andrew, Piepoli, Massimo, McDonagh, Theresa, Riley, Jillian, Hoes, Arno, Pieske, Burkert, Dobrić, Milan, Papp, Zoltan, Mebazaa, Alexandre, Parissis, John, Ben Gal, Tuvia, Vinereanu, Dragos, Brito, Dulce, Altenberger, Johann, Gatzov, Plamen, Milinković, Ivan, Hradec, Jaromír, Trochu, Jean-Noel, Amir, Offer, Moura, Brenda, Lainscak, Mitja, Comin, Josep, Wikström, Gerhard, and Anker, Stefan

Published
2013
Full Text
View/download PDF

38. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry.

Author

Kapłon‐Cieślicka, Agnieszka, Benson, Lina, Chioncel, Ovidiu, Crespo‐Leiro, Maria G., Coats, Andrew J.S., Anker, Stefan D., Filippatos, Gerasimos, Ruschitzka, Frank, Hage, Camilla, Drożdż, Jarosław, Seferovic, Petar, Rosano, Giuseppe M.C., Piepoli, Massimo, Mebazaa, Alexandre, McDonagh, Theresa, Lainscak, Mitja, Savarese, Gianluigi, Ferrari, Roberto, Maggioni, Aldo P., and Lund, Lars H.

Subjects
VENTRICULAR ejection fraction, HEART failure, NATRIURETIC peptides, ACUTE coronary syndrome, GLOMERULAR filtration rate
Abstract

Aims: To perform a comprehensive characterization of acute heart failure (AHF) with preserved (HFpEF), versus mildly reduced (HFmrEF) versus reduced ejection fraction (HFrEF). Methods and results: Of 5951 participants in the ESC HF Long‐Term Registry hospitalized for AHF (acute coronary syndromes excluded), 29% had HFpEF, 18% HFmrEF, and 53% HFrEF. Hospitalization reasons were most commonly atrial fibrillation (more in HFmrEF and HFpEF), followed by ischaemia (HFmrEF), infection (HFmrEF and HFpEF), worsening renal function (HFrEF), and uncontrolled hypertension (HFmrEF and HFpEF). Hospitalization characteristics included lower blood pressure, more oedema and higher natriuretic peptides with lower ejection fraction, similar pulmonary congestion, more mitral regurgitation in HFrEF and HFmrEF and more tricuspid regurgitation in HFrEF. In‐hospital mortality was 3.4% in HFrEF, 2.1% in HFmrEF and 2.2% in HFpEF. Intravenous diuretic (∼80%) and nitrate (∼15%) use was similar but inotrope use greater in HFrEF (16%, vs. HFmrEF 7.4% vs. HFpEF 5.3%). Weight loss and estimated glomerular filtration rate improvement were greater in HFrEF, whereas reduction in natriuretic peptides was similar. Over 1 year post‐discharge, events per 100 patient‐years (95% confidence interval) in HFrEF versus HFmrEF versus HFpEF were: all‐cause death 22 (20–24) versus 17 (14–20) versus 17 (15–20); cardiovascular (CV) death 12 (10–13) versus 8.6 (6.6–11) versus 8.4 (6.9–10); non‐CV death 2.4 (1.8–3.1) versus 3.3 (2.1–4.8) versus 4.5 (3.5–5.9); all‐cause hospitalization 48 (45–51) versus 35 (31–40) versus 42 (39–46); HF hospitalization 29 (27–32) versus 19 (16–22) versus 17 (15–20); and non‐CV hospitalization 7.7 (6.6–8.9) versus 9.6 (7.5–12) versus 15 (13–17). Conclusion: In AHF, HFrEF is more severe and has greater in‐hospital mortality. Post‐discharge, HFrEF has greater CV risk, HFpEF greater non‐CV risk, and HFmrEF lower overall risk. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

41. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology

Author

Pudil, Radek, primary, Mueller, Christian, additional, Čelutkienė, Jelena, additional, Henriksen, Peter A., additional, Lenihan, Dan, additional, Dent, Susan, additional, Barac, Ana, additional, Stanway, Susanna, additional, Moslehi, Javid, additional, Suter, Thomas M., additional, Ky, Bonnie, additional, Štěrba, Martin, additional, Cardinale, Daniela, additional, Cohen‐Solal, Alain, additional, Tocchetti, Carlo Gabriele, additional, Farmakis, Dimitrios, additional, Bergler‐Klein, Jutta, additional, Anker, Markus S., additional, Von Haehling, Stephan, additional, Belenkov, Yury, additional, Iakobishvili, Zaza, additional, Maack, Christoph, additional, Ciardiello, Fortunato, additional, Ruschitzka, Frank, additional, Coats, Andrew J.S., additional, Seferovic, Petar, additional, Lainscak, Mitja, additional, Piepoli, Massimo F., additional, Chioncel, Ovidiu, additional, Bax, Jereon, additional, Hulot, Jean‐Sebastien, additional, Skouri, Hadi, additional, Hägler‐Laube, Eva Simona, additional, Asteggiano, Riccardo, additional, Fernandez, Teresa Lopez, additional, de Boer, Rudolf A., additional, and Lyon, Alexander R., additional

Published
2020
Full Text
View/download PDF

42. Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology

Author

Jaarsma, Tiny, primary, Hill, Loreena, additional, Bayes‐Genis, Antoni, additional, La Rocca, Hans‐Peter Brunner, additional, Castiello, Teresa, additional, Čelutkienė, Jelena, additional, Marques‐Sule, Elena, additional, Plymen, Carla M., additional, Piper, Susan E., additional, Riegel, Barbara, additional, Rutten, Frans H., additional, Ben Gal, Tuvia, additional, Bauersachs, Johann, additional, Coats, Andrew J.S., additional, Chioncel, Ovidiu, additional, Lopatin, Yuri, additional, Lund, Lars H., additional, Lainscak, Mitja, additional, Moura, Brenda, additional, Mullens, Wilfried, additional, Piepoli, Massimo F., additional, Rosano, Giuseppe, additional, Seferovic, Petar, additional, and Strömberg, Anna, additional

Published
2020
Full Text
View/download PDF

43. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology

Author

Chioncel, Ovidiu, primary, Parissis, John, additional, Mebazaa, Alexandre, additional, Thiele, Holger, additional, Desch, Steffen, additional, Bauersachs, Johann, additional, Harjola, Veli‐Pekka, additional, Antohi, Elena‐Laura, additional, Arrigo, Mattia, additional, Ben Gal, Tuvia, additional, Celutkiene, Jelena, additional, Collins, Sean P., additional, DeBacker, Daniel, additional, Iliescu, Vlad A., additional, Jankowska, Ewa, additional, Jaarsma, Tiny, additional, Keramida, Kalliopi, additional, Lainscak, Mitja, additional, Lund, Lars H, additional, Lyon, Alexander R., additional, Masip, Josep, additional, Metra, Marco, additional, Miro, Oscar, additional, Mortara, Andrea, additional, Mueller, Christian, additional, Mullens, Wilfried, additional, Nikolaou, Maria, additional, Piepoli, Massimo, additional, Price, Susana, additional, Rosano, Giuseppe, additional, Vieillard‐Baron, Antoine, additional, Weinstein, Jean M., additional, Anker, Stefan D., additional, Filippatos, Gerasimos, additional, Ruschitzka, Frank, additional, Coats, Andrew J.S., additional, and Seferovic, Petar, additional

Published
2020
Full Text
View/download PDF

44. Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry

Author

Cooper, Lauren B., primary, Benson, Lina, additional, Mentz, Robert J., additional, Savarese, Gianluigi, additional, DeVore, Adam D., additional, Carrero, Juan‐Jesus, additional, Dahlström, Ulf, additional, Anker, Stefan D., additional, Lainscak, Mitja, additional, Hernandez, Adrian F., additional, Pitt, Bertram, additional, and Lund, Lars H., additional

Published
2020
Full Text
View/download PDF

45. Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology

Author

Čelutkienė, Jelena, primary, Lainscak, Mitja, additional, Anderson, Lisa, additional, Gayat, Etienne, additional, Grapsa, Julia, additional, Harjola, Veli‐Pekka, additional, Manka, Robert, additional, Nihoyannopoulos, Petros, additional, Filardi, Pasquale Perrone, additional, Vrettou, Rosa, additional, Anker, Stefan D., additional, Filippatos, Gerasimos, additional, Mebazaa, Alexandre, additional, Metra, Marco, additional, Piepoli, Massimo, additional, Ruschitzka, Frank, additional, Zamorano, Jose Luis, additional, Rosano, Giuseppe, additional, and Seferovic, Petar, additional

Published
2020
Full Text
View/download PDF

48. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.

Author

McDonagh, Theresa A., Metra, Marco, Adamo, Marianna, Gardner, Roy S., Baumbach, Andreas, Böhm, Michael, Burri, Haran, Butler, Javed, Čelutkienė, Jelena, Chioncel, Ovidiu, Cleland, John G.F., Coats, Andrew J.S., Crespo‐Leiro, Maria G., Farmakis, Dimitrios, Gilard, Martine, Heymans, Stephane, Hoes, Arno W., Jaarsma, Tiny, Jankowska, Ewa A., and Lainscak, Mitja

Subjects
HEART failure, TASK forces, CARDIOLOGY, CARDIAC pacing, DIAGNOSIS
Abstract

Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator) (Netherlands), P. Christian Schulze (CPG Review Coordinator) (Germany), Magdy Abdelhamid (Egypt), Victor Aboyans (France), Stamatis Adamopoulos (Greece), Stefan D. Anker (Germany), Elena Arbelo (Spain), Riccardo Asteggiano (Italy), Johann Bauersachs (Germany), Antoni Bayes-Genis (Spain), Michael A. Borger (Germany), Werner Budts (Belgium), Maja Cikes (Croatia), Kevin Damman (Netherlands), Victoria Delgado (Netherlands), Paul Dendale (Belgium), Polychronis Dilaveris (Greece), Heinz Drexel (Austria), Justin Ezekowitz (Canada), Volkmar Falk (Germany), Laurent Fauchier (France), Gerasimos Filippatos (Greece), Alan Fraser (United Kingdom), Norbert Frey (Germany), Chris P. Gale (United Kingdom), Finn Gustafsson (Denmark), Julie Harris (United Kingdom), Bernard Iung (France), Stefan Janssens (Belgium), Mariell Jessup (United States of America), Aleksandra Konradi (Russia), Dipak Kotecha (United Kingdom), Ekaterini Lambrinou (Cyprus), Patrizio Lancellotti (Belgium), Ulf Landmesser (Germany), Christophe Leclercq (France), Basil S. Lewis (Israel), Francisco Leyva (United Kingdom), AleVs Linhart (Czech Republic), Maja-Lisa Løchen (Norway), Lars H. Lund (Sweden), Donna Mancini (United States of America), Josep Masip (Spain), Davor Milicic (Croatia), Christian Mueller (Switzerland), Holger Nef (Germany), Jens-Cosedis Nielsen (Denmark), Lis Neubeck (United Kingdom), Michel Noutsias (Germany), Steffen E. Petersen (United Kingdom), Anna Sonia Petronio (Italy), Piotr Ponikowski (Poland), Eva Prescott (Denmark), Amina Rakisheva (Kazakhstan), Dimitrios J. Richter (Greece), Evgeny Schlyakhto (Russia), Petar Seferovic (Serbia), Michele Senni (Italy), Marta Sitges (Spain), Miguel Sousa-Uva (Portugal), Carlo G. Tocchetti (Italy), Rhian M. Touyz (United Kingdom), Carsten Tschoepe (Germany), Johannes Waltenberger (Germany/Switzerland) All experts involved in the development of these guidelines have submitted declarations of interest. These have been compiled in a report and published in a supplementary document simultaneously to the guidelines. The report is also available on the ESC website www.escardio.org/guidelines For the Supplementary Data which include background information and detailed discussion of the data that have provided the basis for the guidelines see European Heart Journal online. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

49. The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.

Author

Seferović, Petar M., Vardas, Panagiotis, Jankowska, Ewa A., Maggioni, Aldo P., Timmis, Adam, Milinković, Ivan, Polovina, Marija, Gale, Chris P., Lund, Lars H., Lopatin, Yuri, Lainscak, Mitja, Savarese, Gianluigi, Huculeci, Radu, Kazakiewicz, Dzianis, Coats, Andrew J.S., and National Heart Failure Societies of the ESC member countries (see Appendix)

Subjects
HEART failure, LENGTH of stay in hospitals, EPIDEMIOLOGY, MIDDLE-income countries, TOTAL quality management
Abstract

Aims: The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) developed the HFA Atlas to provide a contemporary description of heart failure (HF) epidemiology, resources, reimbursement of guideline-directed medical therapy (GDMT) and activities of the National Heart Failure Societies (NHFS) in ESC member countries.Methods and Results: The HFA Atlas survey was conducted in 2018-2019 in 42 ESC countries. The quality and completeness of source data varied across countries. The median incidence of HF was 3.20 [interquartile range (IQR) 2.66-4.17] cases per 1000 person-years, ranging from ≤2 in Italy and Denmark to >6 in Germany. The median HF prevalence was 17.20 (IQR 14.30-21) cases per 1000 people, ranging from ≤12 in Greece and Spain to >30 in Lithuania and Germany. The median number of HF hospitalizations was 2671 (IQR 1771-4317) per million people annually, ranging from <1000 in Latvia and North Macedonia to >6000 in Romania, Germany and Norway. The median length of hospital stay for an admission with HF was 8.50 (IQR 7.38-10) days. Diagnostic and management resources for HF varied, with high-income ESC member countries having substantially more resources compared with middle-income countries. The median number of hospitals with dedicated HF centres was 1.16 (IQR 0.51-2.97) per million people, ranging from <0.10 in Russian Federation and Ukraine to >7 in Norway and Italy. Nearly all countries reported full or partial reimbursement of standard GDMT, except ivabradine and sacubitril/valsartan. Almost all countries reported having NHFS or working groups and nearly half had HF patient organizations.Conclusions: The first report from the HFA Atlas has shown considerable heterogeneity in HF disease burden, the resources available for its management and data quality across ESC member countries. The findings emphasize the need for a systematic approach to the capture of HF statistics so that inequalities and improvements in care may be quantified and addressed. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

50. Heart Failure Association of the European Society of Cardiology position paper on frailty in patients with heart failure

Author

Vitale, Cristiana, primary, Jankowska, Ewa, additional, Hill, Loreena, additional, Piepoli, Massimo, additional, Doehner, Wolfram, additional, Anker, Stefan D., additional, Lainscak, Mitja, additional, Jaarsma, Tiny, additional, Ponikowski, Piotr, additional, Rosano, Giuseppe M.C., additional, Seferovic, Petar, additional, and Coats, Andrew J., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results